| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Imatinib Mesylate | FAERS: 6 | US FAERS | |
| 2 | Dasatinib | FAERS: 3 | OFFSIDES US FAERS | |
| 3 | Deferasirox | FAERS: 3 | US FAERS | |
| 4 | Imatinib Mesylate | FAERS: 1 | OFFSIDES US FAERS | |
| 5 | Methotrexate | FAERS: 1 | US FAERS | |
| 6 | Mitoxantrone | FAERS: 1 | US FAERS | |
| 7 | Cytarabine | OFFSIDES | ||
| 8 | Daunorubicin | OFFSIDES | ||
| 9 | Etoposide | OFFSIDES | ||
| 10 | Fluconazole | OFFSIDES | ||
| 11 | Mitoxantrone | OFFSIDES | ||
| 12 | Tremorine | OFFSIDES | ||
| 13 | Vincristine | OFFSIDES | ||
| 14 | biapenem | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.